Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Raleigh, NC
NPI: 1003990995Primary Practice Location
DUKE REGIONAL HOSPITAL
3643 N Roxboro St, Durham, NC
Primary Employer
Duke Health Integrated Practice, Inc.
dhip.dukehealth.org
HQ Phone
Get M.D. Thomas's Phone Numberphone_androidMobile
Get M.D. Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
NC State Medical License
1989 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology
Duke University Hospital
Fellowship • Hematology and Medical Oncology
1988 - 1991
Residency • Internal Medicine
1985 - 1988
Indiana University School Of Medicine
medicine.iu.edu
Medical School
Until 1985
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85390Coagulation function screening test with interpretation and report | 62 | 83 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 53 | 56 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 21 | 21 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults.
Authors: Susan Hastings, Juliessa Pavon
Publication Date: 2018-07
Authors: Susan Hastings, Juliessa Pavon, Harvey Cohen
Journal: J Aging Phys Act
Publication Date: 2020-04-24
Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
Authors: Kuderer, Nicole M, Ortel, Thomas L, Francis, Charles W
Journal: J Clin Oncol
Publication Date: 2009-09-08
Lead Sponsor: Scott C. Woller, MD
Collaborators: Bristol-Myers Squibb, University of Utah
Intervention / Treatment: DRUG: Apixaban, DRUG: Warfarin
Lead Sponsor: Takeda
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: BIOLOGICAL: TAK-755
Lead Sponsor: Aspen Global Incorporated
Intervention / Treatment: DRUG: Argatroban, DRUG: Danaparoid Sodium